Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: P2C 9144 Principal Investigator: Picus, Joel
Title: A Phase II Study of Bevacizumab Alone or In Combination with TRC105 in Advanced Renal Cell Cancer
Phase: II Disease Site: Kidney
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to find out whether adding an investigational new drug, TRC105, to a drug called bevacizumab, will result in longer cancer control than bevacizumab alone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)